186 related articles for article (PubMed ID: 1954657)
1. Hemoglobin adducts and urinary mercapturic acids in rats as biological indicators of butadiene exposure.
Osterman-Golkar S; Kautiainen A; Bergmark E; Håkansson K; Mäki-Paakkanen J
Chem Biol Interact; 1991; 80(3):291-302. PubMed ID: 1954657
[TBL] [Abstract][Full Text] [Related]
2. Epoxybutene-hemoglobin adducts in rats and mice: dose response for formation and persistence during and following long-term low-level exposure to butadiene.
Osterman-Golkar SM; Moss O; James A; Bryant MS; Turner M; Bond JA
Toxicol Appl Pharmacol; 1998 May; 150(1):166-73. PubMed ID: 9630466
[TBL] [Abstract][Full Text] [Related]
3. Dose responses for the formation of hemoglobin adducts and urinary metabolites in rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-(14)C]-butadiene.
Booth ED; Kilgour JD; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):213-32. PubMed ID: 15013822
[TBL] [Abstract][Full Text] [Related]
4. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
5. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
[TBL] [Abstract][Full Text] [Related]
6. Haemoglobin adducts of epoxybutanediol from exposure to 1,3-butadiene or butadiene epoxides.
Pérez HL; Lähdetie J; Landin H; Kilpeläinen I; Koivisto P; Peltonen K; Osterman-Golkar S
Chem Biol Interact; 1997 Aug; 105(3):181-98. PubMed ID: 9291996
[TBL] [Abstract][Full Text] [Related]
7. Dose responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-[(14)C]-butadiene.
Booth ED; Kilgour JD; Robinson SA; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):195-211. PubMed ID: 15013821
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of exposure to 1,3-butadiene as a basis for cancer risk assessment.
van Sittert NJ; Megens HJ; Watson WP; Boogaard PJ
Toxicol Sci; 2000 Jul; 56(1):189-202. PubMed ID: 10869468
[TBL] [Abstract][Full Text] [Related]
9. Analysis of diepoxide-specific cyclic N-terminal globin adducts in mice and rats after inhalation exposure to 1,3-butadiene.
Boysen G; Georgieva NI; Upton PB; Jayaraj K; Li Y; Walker VE; Swenberg JA
Cancer Res; 2004 Dec; 64(23):8517-20. PubMed ID: 15574756
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin adducts and micronuclei in rodents after treatment with isoprene monoxide or butadiene monoxide.
Fred C; Grawé J; Törnqvist M
Mutat Res; 2005 Aug; 585(1-2):21-32. PubMed ID: 15925539
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.
Albertini RJ; Sram RJ; Vacek PM; Lynch J; Rossner P; Nicklas JA; McDonald JD; Boysen G; Georgieva N; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):63-77. PubMed ID: 16949064
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of N-terminal valine peptide adducts specific for 1,2-epoxy-3-butene.
Georgieva NI; Boysen G; Upton PB; Jayaraj K; Gold A; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):219-25. PubMed ID: 16860298
[TBL] [Abstract][Full Text] [Related]
13. N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides.
Boysen G; Georgieva NI; Upton PB; Walker VE; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):84-92. PubMed ID: 17084829
[TBL] [Abstract][Full Text] [Related]
14. Urinary mercapturic acids and a hemoglobin adduct for the dosimetry of acrylamide exposure in smokers and nonsmokers.
Urban M; Kavvadias D; Riedel K; Scherer G; Tricker AR
Inhal Toxicol; 2006 Sep; 18(10):831-9. PubMed ID: 16774873
[TBL] [Abstract][Full Text] [Related]
15. High throughput HPLC-ESI(-)-MS/MS methodology for mercapturic acid metabolites of 1,3-butadiene: Biomarkers of exposure and bioactivation.
Kotapati S; Esades A; Matter B; Le C; Tretyakova N
Chem Biol Interact; 2015 Nov; 241():23-31. PubMed ID: 25727266
[TBL] [Abstract][Full Text] [Related]
16. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
Blair IA; Oe T; Kambouris S; Chaudhary AK
Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
[TBL] [Abstract][Full Text] [Related]
17. Use of haemoglobin adducts for biomonitoring exposure to 1,3-butadiene.
Osterman-Golkar SM; Bond JA; Ward JB; Legator MS
IARC Sci Publ; 1993; (127):127-34. PubMed ID: 8070858
[TBL] [Abstract][Full Text] [Related]
18. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
Motwani HV; Törnqvist M
Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers in Czech workers exposed to 1,3-butadiene: a transitional epidemiologic study.
Albertini RJ; Srám RJ; Vacek PM; Lynch J; Nicklas JA; van Sittert NJ; Boogaard PJ; Henderson RF; Swenberg JA; Tates AD; Ward JB; Wright M; Ammenheuser MM; Binkova B; Blackwell W; de Zwart FA; Krako D; Krone J; Megens H; Musilová P; Rajská G; Ranasinghe A; Rosenblatt JI; Rössner P; Rubes J; Sullivan L; Upton P; Zwinderman AH
Res Rep Health Eff Inst; 2003 Jun; (116):1-141; discussion 143-62. PubMed ID: 12931846
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hemoglobin adduct formation in mice and rats after administration of [14C]butadiene or [14C]isoprene.
Sun JD; Dahl AR; Bond JA; Birnbaum LS; Henderson RF
Toxicol Appl Pharmacol; 1989 Aug; 100(1):86-95. PubMed ID: 2763304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
